For each subgroup, we analyzed frequency of thrombolytic treatments, time intervals, and outcomes (3-month modified Rankin Scale score 0-2 as good functional outcome, mortality, symptomatic intracerebral hemorrhage). Results-We included 21 513 patients. Considering the mean expected number of patients treated per hour (0.4) and per day of the week (9.8), if no temporal variations were present, patients were significantly treated more during day hours and weekdays (P<0.0001). Median door-to-needle and onset-to-treatment times were longer for patients treated during night hours and on weekends (P<0.01). After adjustment for confounding variables, treatment during day hours was an independent predictor of good functional outcome (odds ratio, 1.12; 95% confidence interval, 1.04-1.21; P=0.004), and patients treated during weekdays were at risk of higher mortality (odds ratio, 1.15; 95% confidence interval, 1.04-1.28; P=0.008). Conclusions-Frequency of thrombolytic treatment seems to follow the same circadian pattern of stroke incidence, whereas its correspondence to a weekly pattern is less clear. Time of treatment is an independent predictor of outcome. (Stroke. 2014;45:176-184.)
S everal studies reported a higher risk of having cerebrovascular events during the mid-to late-morning and mid-to late-afternoon hours. [1] [2] [3] [4] [5] [6] An increased incidence of stroke has been reported during the weekend and on Monday, 3, 7, 8 whereas other studies reported Wednesday as the most risky day; and others did not find significant variations among the days of the week. [9] [10] [11] Circadian changes of biological hemodynamic and hemostatic processes, including a reduction of fibrinolytic activity with increased thrombogenic condition in the late-morning hours 12 and on weekends, 13 have been advocated to explain temporal variations of stroke onset.
Previous studies described the higher risk-adjusted mortality for patients admitted on weekends and, in general, outside of regular working hours (off-hours). [14] [15] [16] Differences in quality of care provided to patients during off-hours 8, 17, 18 have been proposed as likely explanations of the weekend or off-hour effect.
14 Other studies did not find an independent effect of weekend admission on in-hospital mortality 19, 20 or substantial differences in general outcome between patients not treated Background and Purpose-Temporal variations of thrombolysis delivery and their influence on outcome have been reported with controversial results. In this large cohort study, we evaluated whether thrombolytic treatment has a within-day and weekly variability corresponding to circadian and weekly patterns of ischemic stroke onset, and whether these have impact on clinical outcome. Methods-We retrospectively analyzed patients with acute ischemic stroke receiving intravenous alteplase, prospectively included in the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register. Patients were grouped by treatment on day hours (08:00-19:59) or night hours (20:00-07:59) and treatment on weekdays and weekends.
with thrombolysis with cerebrovascular events occurring during day time and those with stroke onset during night time. 21 Despite strong evidence of safety and efficacy of intravenous (IV) alteplase ≤4.5 hours after symptom onset, 22 thrombolysis is still accessible only for a limited number of patients with ischemic stroke. Hence, it is urgent to understand whether the access to thrombolytic treatment is always guaranteed, and with the same safety and efficacy, irrespective of time and day of treatment. Few recent studies on this issue found controversial results, 16, [23] [24] [25] [26] [27] [28] [29] one reporting higher case fatality rates in patients treated during working hours, 23 whereas another reporting that diurnal IV tissue-type plasminogen activator (t-PA) administration was independently associated with early recanalization and better 90-day functional outcome. 24 Other studies showed that the majority of patients with stroke received thrombolysis during nonworking hours and that time of hospital admission was not an independent predictor of outcome. 16, [25] [26] [27] [28] [29] In a large cohort of patients treated with IV thrombolysis in several centers from European and non-European countries and entered into the Safe Implementation of Treatments in StrokeInternational Stroke Thrombolysis Register (SITS-ISTR), we aimed to evaluate whether thrombolytic treatment for acute ischemic stroke has a within-day variation corresponding to the circadian pattern of stroke onset and a weekly variability, and whether these have an impact on clinical outcome.
Methods

Study Population
We retrospectively analyzed data of patients with acute ischemic stroke receiving IV thrombolysis during a period of 6 years, and prospectively registered in the SITS-ISTR, a prospective, multinational, Internetbased register of IV thrombolysis (www.sitsinternational.org). 30 Patients were selected according to criteria reported in the European summary of product characteristics, although the register also includes patients treated without a strict adhesion to some contraindications of the treatment protocol. Approval by local ethics committees or patient consent was obtained in countries where required; other countries approved the register as an anonymized audit.
For each patient, demographic and clinical characteristics were collected, including time intervals for treatment (that is, onset-to-door time, door-to-imaging time, door-to-needle time, and onset-to-treatment time), radiological early ischemic signs, and hyperdense middle cerebral artery sign (HMCAS). For the purposes of the present study, time and day of thrombolytic treatment were also considered.
Outcome Measures
We considered the following outcome measures: symptomatic intracerebral hemorrhage (SICH), mortality, and functional independence at 3-month follow-up.
SICH per SITS-MOST protocol 30 was defined as local or remote parenchymal hemorrhage type 2 31 on the 22-to 36-hour post-treatment imaging scan combined with a neurological deterioration of ≥4 points on the National Institutes of Health Stroke Scale (NIHSS) from baseline or from the lowest NIHSS value between baseline and 24 hours, or leading to death. SICH per National Institute of Neurological Disorders and Stroke (NINDS) 32 was intended as any hemorrhage combined with any neurological deterioration (NIHSS score ≥1) or that leads to death within 7 days. Finally, SICH according to the European Cooperative Acute Stroke Study (ECASS) II trial 31 was any hemorrhage plus a neurological deterioration of ≥4 points on the NIHSS from baseline or from the lowest NIHSS value after baseline to 7 days or leading to death. Hemorrhage rates were calculated from computed tomography or MRI scans done between 22 and 36 hours after therapy and also from any additional post-treatment scan evaluated at the local centers.
For the death end point, survival was assessed ≤3 months from therapy through contact with the patient's family or caregiver.
Functional independence was defined as a modified Rankin Scale score of 0 to 2 (good functional outcome) at 3 months after stroke onset. Additional outcome measure was no or minimal disability (ie, modified Rankin Scale score of 0-1 at 3 months).
Statistical Analysis
For the purposes of this study, to obviate the wide heterogeneity of work shift organization and definition of working and nonworking hours/days because of the multicenter and multinational nature of the SITS-ISTR, we divided the population into paired subgroups by t-PA treatment time, considering 2 exact 12-hour intervals as day (08:00-19:59) versus night (20:00-07:59) hours, and 2 exact patterns of days for weekdays, from Sunday midnight to Friday midnight, versus weekend days, from Friday midnight to Sunday midnight (although, for example, Saturday, at least in the morning, is usually considered a working day in some countries of Southern Europe and a nonworking day in most countries of Northern Europe). We calculated frequencies of thrombolytic treatments for each subgroup. We also considered distribution of treatments along 6-hour time intervals (00:00-5:59; 06:00-11:59; 12:00-17:59; 18:00-23.59). The paired subgroups were compared with each other to find possible significant differences in the frequencies of thrombolysis.
Assuming that stroke onset was evenly distributed during the hours of the day and the days of the week, biasing toward the null hypothesis of lack of circadian variation, the χ 2 test for goodness of fit to the null model of equal distribution of thrombolytic treatments was applied to the observed number of thrombolytic treatments compared with the expected number if no temporal variation was present for the day versus night hours and weekdays versus weekends.
Then we performed the same analysis by considering only countries that entered >900 treatments (ie, 150 per year) in the registry during the study period.
Continuous variables were expressed as median (interquartile range) or mean (±SD), categorical variables as counts (percentages), and we calculated percentage proportions by dividing the number of events by the total number of patients, excluding missing or unknown cases. Univariate analysis with Mann-Whitney U test and χ 2 test was performed to compare demographics, clinical characteristics, and outcome measures of the paired subgroups.
To evaluate whether treatments by hour of the day and day of the week were independently related to outcome measures, 2 different multivariate logistic regression models for each outcome measure were performed, 1 including day/night treatment and another including weekday/weekend treatment, along with variables presenting with univariate associations of P≤0. 25 , and those variables potentially influencing outcome such as age, sex, baseline NIHSS, and time intervals to treatment, irrespective of the univariate association. Statistical significance was set at P<0.05. All statistical analyses were performed with Statistica version 7.0.
Results
During a period of 6 years, 21 513 patients receiving IV t-PA were included in the SITS-ISTR, of whom 15 462 (71.9%) were treated during day hours (8:00-19:59) and 6051 (28.1%) during night hours (20:00-07:59; Considering the countries that entered >900 patients in the registry during the study period, in each country, patients were more frequently treated during day hours compared with the expected numbers (P<0.0001; Figure 1A ), whereas no difference was found between weekdays and weekends, except for United Kingdom, where patients were more frequently treated during weekdays (OR, 1.77; 95% CI, 1.52-2.06; P<0.0001; Figure 1B) . Tables 2 and 3 show demographic, baseline characteristics, and outcome measures of the subgroups. Patients' characteristics were mostly homogeneous, particularly with regard to the baseline stroke severity, across all the subgroups, except for some significant small differences. Patients treated during day hours were more likely to be older (P<0.001), women (P=0.026), with less prevalent independency before stroke (P=0.001), a higher proportion of stroke because of large vessel disease other than substantial carotid stenosis (P=0.014), and fewer stroke mimics (P=0.020). Patients treated in night hours had more frequently atrial fibrillation (P=0.008), were more likely current smokers (P<0.0001), had baseline serum glucose levels 1 mg/dL higher (P=0.003) and diastolic blood pressure 1 mm Hg higher (P=0.026) than those treated during day hours. No significant differences in HMCAS proportions were observed between day and night hours (P=0.89), even when we considered the 6-hour groups (00:00-5:59: 18.8%; 06:00-11:59: 18.7%; 12:00-17:59: 18.9%; 18:00-23.59: 18.2%; P=0.79). Among those with HMCAS at baseline, follow-up imaging showed reversal of the arterial sign, as a marker of recanalization, in the same proportions of patients treated during day and night hours (53.9% versus 52.1%; P=0.34), also in the 6-hour groups (00:00-5:59: 52.7%; 06:00-11:59: 54.4%; 12:00-17:59: 54.3%; 18:00-23.59: 52.7%; P=0.59). Patients treated during weekdays had higher proportions of congestive heart failure (P=0.014) and early ischemic signs on baseline neuroimaging (P=0.002), whereas the proportions of HMCAS found at baseline (P=0.84) and after thrombolysis (P=0.20) were similar to those observed during weekends. Median onsetto-door time was 1 minute longer for patients treated during night hours (P=0.002), and median door-to-needle time and onset-to-treatment time were longer for patients treated both during night hours (P<0.001 and P<0.001, respectively) and on weekends (P=0.001 and P<0.001, respectively; Table 2 ).
With regard to the outcome measures, Figure 2 shows the distribution of modified Rankin Scale in the subgroups paired by time of the day ( Figure 2A ) and day of the week ( Figure  2B ). Multivariate logistic regression analysis confirmed the significant results of the univariate analysis for outcomes (Table 3 ). In particular, treatment during day hours was an independent predictor of good functional outcome (OR, 1.12; 95% CI, 1.04-1.21; P=0.004) and no or minimal disability (OR, 1.09; 95% CI, 1.01-1.17; P=0.03), and of a lower risk of developing SICH/NINDS (OR, 0.84; 95% CI, 0.75-0.95; P=0.005), whereas treatment during weekdays was related to a higher mortality rate (OR, 1.15; 95% CI, 1.04-1.28; P=0.008).
Discussion
This study shows that temporal variability of thrombolytic treatment seems to correspond to circadian rhythm of stroke onset, maintaining a similar diurnal pattern. [1] [2] [3] [4] [5] [6] We found the highest proportion of treatments from noon to 17:59, which may be explained by the delay between stroke onset and hospital arrival, and the lower proportion of treatments between midnight and 5.59 AM, with a 50% increase during day hours and a 50% decrease during night hours compared with the expected numbers if no within-day variation was present.
In our study, there were more thrombolyses during weekdays, with the highest numbers of treatments on Wednesday and Monday, with an overall increase of 4.1% during the weekdays and a decrease of 9.2% during the weekend compared with the expected numbers. When we considered the countries that included >900 patients in the registry, no difference was found in treatment frequencies between weekdays and weekends, except for United Kingdom where patients were significantly more frequently treated during weekdays, confirming the results of a previous study. 33 These data would agree with reported weekly variation in stroke onset, the incident of which would peak on Monday or on Wednesday and would be the lowest during the weekend. 7, 10 In contrary to our observations, in other studies, the majority of patients with stroke received thrombolysis during the weekend, 16, 20, [25] [26] [27] particularly in comprehensive or primary stroke centers compared with nonstroke centers. 20 Some authors reported stroke onset as being more frequent during the weekend, 3, 6, 8 and hence, it is not clear whether the differences found in our study have to be related to weekly changes of stroke onset or to differences in stroke service organization.
Patients' characteristics were mostly homogeneous across all the subgroups, particularly, as previously reported, 23, 28 with regard to the median baseline stroke severity. There is the exception for some, more statistically than clinically, significant differences, probably related to the large sample size that allows the detection of even small imbalances. That could reflect the lack of a substantial influence of time or day of treatment on patient selection for thrombolysis. We did not find statistical differences in the door-to-imaging time between the paired subgroups, suggesting that there were no disparities at least in the availability of diagnostic procedures, similar to what was reported in recent studies. 23, 28 The longer door-to-needle time and onset-to-treatment time in the range of a few minutes during night hours and on weekends may suggest a tendency to a delay, although little, in certain procedures for the management of patients with stroke during these time periods.
Regardless of the statistical significance, differences in outcome measures between the paired subgroups were relatively small, but treatment during day hours resulted as an independent predictor of good functional outcome and no or minimal disability and of a lower risk of developing SICH/ NINDS. The worse outcomes of patients treated during night hours might be related to the longer time intervals from stroke onset to therapy and to the higher proportion of patients with atrial fibrillation, an important cardiological comorbidity that can have an influence on functional recovery. 34 Longer time intervals might speculatively point at differences in quality of care provided to patients during night hours, which could potentially make the confirmation of eligibility for thrombolysis more difficult, although we do not have data to support this hypothesis. Besides an off-hour effect, circadian rhythm in the efficacy of thrombolysis might also account for these differences in outcome. In fact, t-PA seems to be more effective particularly during diurnal hours, whereas a higher resistance to thrombolysis in the early morning, associated with plasminogen activator inhibitor-1 level increase, has been reported. 12, [35] [36] [37] This has also been suggested by a significant difference in the proportion of diurnal and nocturnal early recanalization 2 hours after t-PA bolus. 24 In the SITS cohort, data on early recanalization are not available, whereas we found the same proportion of reversal of the HMCAS, a surrogate marker of recanalization, 38 22 to 36 hours after diurnal or nocturnal treatment. Other potential biological hemostatic mechanisms, such as circadian changes of platelet activity and diurnal variations in thrombus composition, might be involved in the temporal differences of thrombolytic treatment efficacy. 39, 40 Patients treated during weekdays were more at risk of having a higher mortality. Similar to our study, Bodenant et al 23 reported an unexpected higher 7-day and 3-month mortality in patients treated during working hours compared with those treated during nonworking hours, suggesting that probably during the working hours, the presence of more expert staff members, such as stroke neurologists, could lead to a higher number of protocol violations with a consequently mild increase of the mortality rate compared with the nonworking hours, when nonstroke neurologists probably tend to follow the protocol more strictly. Unfortunately, we cannot verify this hypothesis because we do not have data on organizational aspects of stroke care across the centers. Other factors might have had an impact on our results, such as aversion to seek medical care during the weekend or travel outside cities during weekends, which may render the weekend population in the catching area of a center different from that on weekdays. But, again, it is impossible to evaluate whether this was the case from the SITS-ISTR database and hence, this finding should be further evaluated in prospective studies.
Our results are partially conflicting with some studies on patients with stroke regardless of thrombolytic treatment, reporting not only a worse functional outcome but also an increased mortality during the weekend and on Mondays. 7, [14] [15] [16] In other studies, the off-hour effect seems not to exist in comprehensive stroke centers with 24 hour/7 day availability of expert staff and advanced imaging. 19, 20 Some authors argued that the weekend effect might be an artifact because the tendency toward a higher weekend fatality disappeared when stroke onset time, and not hospital admission time, was taken into account by eliminating the bias of the potential exclusion of nonfatal cases having deferred admission. 41 Finally, other studies, some of which specifically focused on patients treated with thrombolysis, did not observe a night or weekend effect. [25] [26] [27] [28] [29] All those studies were conducted in single or few centers in a single country and hence were at risk for center effects, and their results could not be generalized.
This study has some limitations. The SITS register includes only patients treated with t-PA, therefore, it is difficult to confirm whether the temporal variations we observed in the number of treatments simply corresponds to the same temporal pattern that stroke incidence could have in the relative population. The absence of the denominator of patients with acute stroke evaluated during the different time periods did not allow us also to identify those subjects who were excluded from treatment because of stroke onset during night or early 
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in the morning and too-late hospital arrival because of lack of witnesses or evidence of symptoms at wake-up in the morning. We do not have detailed information about the structural and personnel stroke care organization of each center, and hence, we cannot exclude that temporal variation in thrombolysis delivery may reveal a lack of homogeneity in acute stroke care services. A survey published in 2007, conducted all over Europe in a large random sample of hospitals, showed that only few centers provide an optimal level of care and meet the criteria listed by the European Stroke Initiative. 42 In fact, when we considered the countries that included >900 patients in the registry, the weekend effect on thrombolysis use disappeared. The heterogeneity across the participating centers and countries in the definition of nonworking/working hours and of nonworking/working days, including some local religious or national feasts, might have had an influence on the results, but the wide definitions we adopted may have, at least partially, balanced this limitation.
Another important limitation of this study is that it is a retrospective analysis of data collected prospectively, but because the register is about a specific treatment with a strict protocol on the time window, we hypothesized that there was not bias of reporting stroke onset and treatment time. Moreover, there are no reasons to assume that recording errors on mortality and outcome are significantly different between the paired subgroups.
The major strength of this study is the large sample size, which allowed us to detect small differences and to reach some reasonable results. Moreover, this is a multicenter study, including expert and nonexpert centers, which gives more generalizability and a good external validity to our results.
In conclusion, we found that the number of thrombolytic treatments delivered follows the same diurnal/morning pattern of stroke incidence, but it is difficult to draw definitive conclusions for a weekly temporal pattern. Time of treatment is an independent predictor of outcome in our large multicenter cohort study. Our results indicate that each center needs to carefully review local procedures and can give preliminary information that, if confirmed in future prospective studies, could definitely address whether differences in outcomes and numbers of treated patients are natural variations or consequence of inappropriate resource allocation. funding sources were involved in this study design, patient recruitment, data collection, data analysis, data interpretation, article writing, the decision to submit it for publication, or any aspect pertinent to the study. Authors have not been paid to write this article by a pharmaceutical company or other agency. The corresponding author had full access to all the study data, takes responsibility for the integrity of data and accuracy of data analysis, and had final responsibility for the decision to submit for publication. 一些研究报道上午和下午中后段时间脑血管事件发生的风险更 高 [1] [2] [3] [4] [5] [6] 。有研究认为周末和周一卒中发生率增高 [3, 7, 8] ，一些研究则认 为周三是卒中发生风险最高的一天，但也有研究认为一周内每天卒中 发生风险没有显著差异 [9] [10] [11] 。血流动力学和凝血过程的节律变化包括 上午后段时间 [12] 和周末 [13] 血液中纤溶活性降低、血栓形成条件增加， 已用于解释卒中发生的时间差异。 既往研究发现周末和正常工作时间以外时间（下班时间）收治患 者的校正后死亡率更高 [14] [15] [16] 。非工作时间向病人提供的护理质量的差 异 [8, 17, 18] 可用于解释周末和下班效应 [14] 。其它研究并未发现周末住 院对卒中患者的住院死亡率有独立影响 [19, 20] ，而对于未进行溶栓治 疗的卒中患者而言，日间和夜间发病的总体结局无明显差异 [21] 。 尽管有力的证据证实起病 4.5 小时内进行静脉阿替普酶治疗安 全、有效 [22] ，但仅有少部分缺血性卒中患者能够获得溶栓治疗。因 此，我们急需了解不论是何时何日治疗，溶栓是否可以保证进行，且 具有相同的安全性和有效性。近来关于这方面的研究结果存在争议 [16, [23] [24] [25] [26] [27] [28] [29] ，其中一项研究显示工作时间内接受静脉组织型纤溶酶原激活剂 （tissue-type plasminogen activator, t-PA） 治 疗 的 患 者 死 亡 率更高 [23] ，而另一项研究则报道日间接受 rt-PA 治疗与早期血管再 通及 90 天功能恢复良好有关 [24] 。其它研究发现大部分卒中于非工作 时间接受溶栓及住院不是临床结局的独立预测因素 [16, [25] [26] [27] [28] [29] 而就溶栓登记中纳入超过 900 例溶栓患者的国家而言，除英国工作日 治疗比例高于周末外，其它国家在工作日和周末间治疗率无差异，英 国的数据与以往的一项研究结果一致 [33] 。这些数据符合每周卒中发生 的规律，即：周一或周三达到高峰，周末最少 [7.10] 。与我们观察相反的 是，一些研究发现大多数患者接受溶栓治疗是在周末 [16, 20, [25] [26] [27] ，尤其 是综合性或初级卒中中心（与非卒中中心相比较） [20] 。一些学者报道 卒中更易于周末发生 [3, 6, 8] [39, 40] 
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